INVESTOR

Overview

Outlook On Exports Of Indian Pharmaceutical

  • India is the world’s largest provider of generic medicines; the country’s generic drugs  account for 20 per cent of global generic drug exports (in terms of volumes). Indian
    drugs are exported to more than 200 countries in the world, with the US as the key market.
  • Indian pharma companies are capitalising on export opportunities in regulated and semi-regulated markets.
  • Pharmaceutical exports from India reached US$ 17.27 billion in FY18 and US$ 10.80 billion in FY19 (up to October 2018). Pharmaceutical exports include bulk drugs, intermediates, drug formulations, biologicals, Ayush & herbal products and surgicals.
  • The US is the biggest export destination for Indian pharma product is the US. In FY18, 31 per cent of India’s pharma exports were to the North America, followed by 19.4 percent to Africa and 15.9 per cent to the European Union
Major Export Destinations in India’s Pharma Export in FY18 (%)
  • North America
  • Africa
  • EU
  • ASEAN
  • LAC
  • Middle East
  • Others

Pharmaceutical Exports from India (US$ billion)

  • US$ billion